ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
会议论文

Perioperative toripalimab plus platinum-doublet chemotherapy vs chemotherapy in resectable stage II/III non-small cell lung cancer (NSCLC): Interim event-free survival (EFS) analysis of the phase III Neotorch study.

Lu, Shun; Wu, Lin; Zhang, Wei; Zhang, Peng; Wang, Wenxiang; Fang, Wentao; Xing, Wenqun; Chen, Qixun; Mei, Jiandong; Yang, Lin; Tan, Lijie; Sun, Xiaohong; Xu, Shidong; Hu, Xiaohua; Yu, Guohua; Yu, Dongliang; Shan, Jinlu; Yang, Nong; Chen, Yuping; Tian, Hui复旦大学; 南昌大学; 山东大学; 汕头大学; 上海交通大学; 哈尔滨医科大学; 四川大学; 郑州大学; 中国科学院研究生院; 1
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)2023-11-3
29被引17阅读
引用收藏
分享
相关
加载中…
  • Perioperative toripalimab plus platinum-doublet chemotherapy vs chemotherapy in resectable stage II/III non-small cell lung cancer (NSCLC): Interim event-free survival (EFS) analysis of the phase III NEOTORCH study
    Lu, Shun; Wu, Lin; Zhang, Wei; Zhang, Peng; Wang, Wenxiang; Fang, Wentao; Xing, Wenqun; Chen, Qixun; Mei, Jiandong; Yang, Lin; Tan, Lijie; Sun, Xiaohong; Xu, Shidong; Hu, Xiaohua; Yu, Guohua; Yu, Dongliang; Shan, Jinlu; Yang, Nong; Chen, Yuping; Tian, HuiAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 2023-06-02 To 2023-06-06.被引 6
  • Final overall survival and biomarker analyses of CHOICE-01: A double-blind randomized phase 3 study of toripalimab versus placebo in combination chemotherapy for advanced NSCLC without EGFR/ALK mutations
    Wang, Jie; Wang, Zhijie; Wu, Lin; Li, Baolan; Cheng, Ying; Li, Xiaoling; Wang, Xicheng; Han, Liang; Wu, Xiaohong; Fan, Yun; Yu, Yan; Lv, Dongqing; Shi, Jianhua; Huang, Jianjin; Zhou, Shaozhang; Han, Baohui; Sun, Guogui; Guo, Qisen; Ji, Youxin; Zhu, XiaoliAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 2023-06-02 To 2023-06-06.
  • EXTENTORCH: A randomized, phase III trial of toripalimab versus placebo, in combination with chemotherapy as a first-line therapy for patients with extensive stage small cell lung cancer (ES-SCLC)
    Cheng, Y.; Liu, Y.; Zhang, W.; Wu, L.; Zhou, C.; Wang, D.; Xia, B.; Bi, M.; Fu, X.; Li, C.; Chen, G.; Lv, D.; Zhao, Y.; Huang, J.; Li, M.; Yi, T.; Huang, X.; Yang, R.; Chen, Z.; Wang, Y.Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), Barcelona, SPAIN, 2023-10-20 To 2023-10-24.
查看全部 →

会议信息

会议名称
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)
会议日期
2023-11 至 2023-11
论文集名
JOURNAL OF CLINICAL ONCOLOGY
发表日期
2023-11-03
资助标注
Shanghai Junshi Biosciences Co., Ltd.
收录
ISTP · SCIE

作者

  • L

    Lu, Shun (第一作者)

  • W

    Wu, Lin

查看全部 20 位作者收起作者
  • Z

    Zhang, Wei

  • Z

    Zhang, Peng

  • W

    Wang, Wenxiang

  • F

    Fang, Wentao

  • X

    Xing, Wenqun

  • C

    Chen, Qixun

  • M

    Mei, Jiandong

  • Y

    Yang, Lin

  • T

    Tan, Lijie

  • S

    Sun, Xiaohong

  • X

    Xu, Shidong

  • H

    Hu, Xiaohua

  • Y

    Yu, Guohua

  • Y

    Yu, Dongliang

  • S

    Shan, Jinlu

  • Y

    Yang, Nong

  • C

    Chen, Yuping

  • T

    Tian, Hui

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417